Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/4598Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Dr. Veena Varier | - |
| dc.date.accessioned | 2022-12-10T05:47:17Z | - |
| dc.date.available | 2022-12-10T05:47:17Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/4598 | - |
| dc.description.abstract | ABSTRACT INTRODUCTION Type 2 diabetes mellitus is one component of metabolic syndrome, which includes impaired glucose tolerance, hypertension, obesity, and dyslipidemia. White blood cell (WBC) count is linked to various components of metabolic syndrome, and subclinical inflammation may be associated with the increased cardiovascular risk in patients with impaired glucose tolerance. Neutrophil lymphocyte ratio (NLR) is an essential marker of systemic inflammation and an indicator of increased risk for cardiovascular events in patients with metabolic syndrome. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | A study on neutrophil-lymphocyte ratio and plateletlymphocyte ratio as an assessment tool of glycemic control in type 2 diabetes mellitus patients | en_US |
| dc.title | A study on neutrophil-lymphocyte ratio and plateletlymphocyte ratio as an assessment tool of glycemic control in type 2 diabetes mellitus patients | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Department of Pathology | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Dr Veena Varier Marged .pdf | 2.27 MB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.